CVN-766

N/A

Report date: 2022/11/20 17:06:58
NME

Base Information

Drug NameCVN-766
Drug Alias NameCVN-766
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCerevance LLC
China Registration ClassN/A

Develop Information

Active CompaniesCerevance LLC
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A